The world’s attention has been on cannabis for the past year or two. A controversial plant, hemp, a variety of cannabis that doesn’t get you high, had been outlawed in most territories until recently. This can be traced back to cannabidiol, a hemp extract flush with potent medicinal properties that has captured the world by storm.
Although most of the medical claims haven’t been clinically tried and proven yet, users swear by CBD, saying it’s effective against everything from anxiety and chronic pain to insomnia and high blood pressure. Cannabidiol’s biggest draw, perhaps, is that it offers consumers a versatile natural alternative to…
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire is part of the InvestorBrandNetwork.